Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
University of California, Irvine
University of California, Irvine
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
City of Hope Medical Center
University of Pittsburgh
Vall d'Hebron Institute of Oncology
M.D. Anderson Cancer Center
University of Kansas Medical Center
University of Nebraska
University of Nebraska
The Christie NHS Foundation Trust
Sheba Medical Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Thomas Jefferson University
Fred Hutchinson Cancer Center
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Western Regional Medical Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
University of Chicago
Baylor Research Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)